High Incidence of Post–Lumbar Puncture Headaches in Patients With Multiple Sclerosis Treated With Natalizumab: Role of Intrathecal Leukocytes
Olaf Stüve(Southwestern Medical Center), Michael K. Racke(Quest Diagnostics (United States)), J. Theodore Gina, Mahendra Pratap Singh(Deen Dayal Upadhyaya Gorakhpur University), Elliot M. Frohman(Stanford University), Wei Hu, Michael J. Olek(Touro University Nevada), Nancy Monson, Petra D. Cravens, J. Theodore Phillips(University of Maryland, Baltimore), Bernhard Hemmer(Munich Cluster for Systems Neurology)
Cited by 3
Related Papers
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
|New England Journal of Medicine|2016|2k
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
|New England Journal of Medicine|2016|1.9k
Multiple sclerosis
|The Lancet|2018|1.8k